Synthetic method of phenanthridone compound based on visible light catalysis
By performing cyclization reaction under the action of photocatalyst and alkali, the problems of harsh reaction conditions and low yield in the synthesis of phenanthine compound are solved, and the efficient synthesis of phenanthine compound is achieved under the blue light room temperature, reducing the Cost and yields increased.
Patent Information
- Application Number
- CN202410966257.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-12-03
AI Technical Summary
The synthesis method of phenanthinone compounds has problems of harsh reaction conditions and low yields, which has led to the development of new synthesis methods becoming a scientific problem that needs to be solved urgently.
Using a method based on visible light catalysis, N-aryl o-iodobenzamide derivatives form phenyl radicals under the action of photocatalysts and bases, and cyclization reactions form phenanthinetone compounds. The reaction conditions are mild and yields are High, easy to separate.
The reaction is carried out at room temperature under blue light, with mild reaction conditions, and the use of cheap and easy-to-get potassium polysulfide as the photocatalyst, which reduces the cost, has high reaction efficiency, and is easy to separate and purify the product.
Smart Images

Figure CN119059968A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of organic catalysis, and in particular to a method for synthesizing phenanthridinone compounds based on visible light catalysis. Background Art
[0002] Phenanthridone is an important component unit of natural alkaloids and bioactive molecules. Phenanthridone compounds are widely present in natural products and drug molecules, and have unique pharmacological and biological activities, such as high efficiency anti-leukemia, anti-tumor, anti-HIV, anti-virus, and can inhibit the activity of acetylcholinesterase. Some of them have been used to treat myasthenia gravis and nervous system diseases. For example, PJ-34 is a cell-permeable PARP inhibitor, and ARC-11 has Top1 targeting activity and obvious anti-tumor activity. Phenaglydon and Crinasiadine are common natural products in Asteraceae plants, which have anti-inflammatory and anti-cancer effects. At present, the synthesis method of phenanthridone compounds has certain limitations, mainly including harsh reaction conditions and low yield. Therefore, the development of a new synthesis method for preparing phenanthridone compounds has become a scientific problem to be solved urgently. Summary of the invention
[0003] In view of this, the purpose of the present invention is to propose a method for synthesizing phenanthridinone compounds based on visible light catalysis, which has the advantages of mild reaction conditions, high reaction yield, easy separation, wide adaptability, and simple operation.
[0004] Based on the above purpose, the present invention provides a method for synthesizing phenanthridinone compounds based on visible light catalysis, wherein the method uses an N-aryl o-iodobenzamide derivative as a raw material, and under the excitation of a photocatalyst and the catalysis of a base, hydrogen iodide is removed to form a phenyl radical, and then a cyclization reaction occurs to generate a phenanthridinone compound;
[0005] The structural formula of the N-aryl o-iodobenzamide derivative is shown in Formula I below:
[0006]
[0007] The structural formula of the phenanthridinone compound is shown in Formula II below:
[0008]
[0009] Among them, R 1 is one of hydrogen, fluorine, chlorine, bromine, methyl or methoxy; the R 2 It is one of hydrogen, fluorine, chlorine, bromine, methyl, methoxy, cyano, trifluoromethyl or tert-butyl.
[0010] The synthetic reaction formula is as follows:
[0011]
[0012] Further, the phenanthridinone compound represented by formula II is preferably:
[0013]
[0014] Preferably, the synthesis method specifically comprises the following steps:
[0015] 1) Adding the raw material of formula I, the photocatalyst and the base into a Shrek tube in sequence;
[0016] 2) Place the Shrek tube into a glove box and add a reaction solvent into the glove box;
[0017] 3) Move the Shrek tube out of the glove box and place it under blue light for reaction at room temperature;
[0018] 4) After the reaction is completed, the reaction mixture in the Shrek tube is transferred to a separatory funnel and ethyl acetate is added for extraction;
[0019] 5) collecting the ethyl acetate organic phase, drying it with anhydrous sodium sulfate, filtering it with a funnel, and concentrating the filtrate with a rotary evaporator to dryness;
[0020] 6) The obtained concentrate is separated and purified by column chromatography to obtain the final phenanthridinone compound.
[0021] Optionally, the photocatalyst is one or a combination of 10-mesityl-10-H-phenothiazine, ammonium tetrathiotungstate, tri(2,2″-bipyridyl)ruthenium(I) chloride hexahydrate or potassium polysulfide, preferably potassium polysulfide.
[0022] Optionally, the base is one or a combination of potassium tert-butoxide, sodium tert-butoxide, potassium carbonate, cesium carbonate, triethylamine, and preferably potassium tert-butoxide.
[0023] Preferably, the molar ratio of the raw material of formula I to the photocatalyst and the base is: 1:0.1-0.01:1-5, preferably 1:0.05:3.
[0024] Optionally, the reaction solvent is selected from one or more of acetonitrile, tetrahydrofuran, acetone, toluene, and 1,4-dioxane, preferably toluene; the amount of the reaction solvent is based on the substrate formula I raw material, so that the concentration range of the formula I raw material in the solvent is 0.05-0.10M, preferably 0.10M.
[0025] In step 2), when adding the reaction solvent toluene, it is necessary to operate in a glove box to keep the reaction in anhydrous, oxygen-free and nitrogen atmosphere.
[0026] Preferably, the eluent used for the separation and purification is a mixture of petroleum ether and ethyl acetate, and the ratio of petroleum ether to ethyl acetate is 10:1-5:1, preferably 5:1.
[0027] The room temperature irradiation reaction time is 1-12 hours, preferably 1 hour.
[0028] Preferably, the wavelength range of the blue light is 420-427 nm, more preferably 427 nm.
[0029] The blue light source is a blue light lamp, and the power of the blue light lamp is 5-40W, preferably 40W.
[0030] Beneficial effects of the present invention:
[0031] (1) The present invention provides a method for synthesizing phenanthridinone compounds based on visible light catalysis. The method can complete the reaction at room temperature under the irradiation of a blue light lamp, does not require a high temperature environment, and the reaction conditions are relatively mild.
[0032] (2) The present invention uses cheap and readily available potassium polysulfide as a reaction photocatalyst, and does not require expensive metal photocatalysts such as iridium and ruthenium, so the reaction cost is low and the reaction efficiency is high.
[0033] (3) The reaction is simple to operate, the product is easy to separate, and the substrate has wide adaptability. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only for the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0035] Figure 1 The phenanthridinone obtained in Example 1 1 Schematic diagram of H NMR;
[0036] Figure 2 The phenanthridinone obtained in Example 1 13 Schematic diagram of C NMR;
[0037] Figure 3 The mixture of 2-methylphenanthridinone and 3-methylphenanthridinone obtained in Example 2 1 Schematic diagram of H NMR;
[0038] Figure 4 The mixture of 2-methylphenanthridinone and 3-methylphenanthridinone obtained in Example 2 13 Schematic diagram of C NMR;
[0039] Figure 5 The 2-trifluoromethylphenanthridinone obtained in Example 3 1 Schematic diagram of H NMR;
[0040] Figure 6 The 2-trifluoromethylphenanthridinone obtained in Example 3 13 Schematic diagram of C NMR;
[0041] Figure 7 The 3-trifluoromethylphenanthridinone obtained in Example 3 1 Schematic diagram of H NMR;
[0042] Figure 8 The 3-trifluoromethylphenanthridinone obtained in Example 3 13 Schematic diagram of C NMR;
[0043] Fig. 9 The 2-tert-butylphenanthridinone obtained in Example 4 1 Schematic diagram of H NMR;
[0044] Fig.10 The 2-tert-butylphenanthridinone obtained in Example 4 13 Schematic diagram of C NMR;
[0045] Fig.11 The 3-tert-butylphenanthridinone obtained in Example 4 1 Schematic diagram of H NMR;
[0046] Fig.12 The 3-tert-butylphenanthridinone obtained in Example 4 13 Schematic diagram of C NMR;
[0047] Fig.13 The 10-methylphenanthridinone obtained in Example 5 1 Schematic diagram of H NMR;
[0048] Fig.14 The 10-methylphenanthridinone obtained in Example 5 13 Schematic diagram of C NMR. DETAILED DESCRIPTION
[0049] In order to make the objectives, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments.
[0050] It should be noted that, unless otherwise defined, the technical terms or scientific terms used in the present invention should have the common meanings understood by persons having ordinary skills in the field to which the present invention belongs.
[0051] Example 1
[0052] The structural formula of the phenanthridinone compound of this embodiment is as follows:
[0053]
[0054] The synthesis method of this embodiment is as follows: 2-iodo-N-(phenyl)benzamide (64.6 mg, 0.2 mmol), potassium polysulfide (1.12 mg, 0.01 mmol), potassium tert-butoxide (67.3 mg, 0.6 mmol) are sequentially loaded into a Shrek tube, toluene (2 mL, 0.1 M) is added to the glove box, the Shrek tube is removed from the glove box, and the mixture is stirred under a 427 nm (40 W) blue light lamp at room temperature for 1 h. After the reaction is completed, ethyl acetate is added to the mixture for extraction and separation, the ethyl acetate organic phase is collected and dried with anhydrous sodium sulfate, and then filtered with a funnel, the filtrate is concentrated by a rotary evaporator under reduced pressure to remove the solvent, and the concentrate is purified by column chromatography (eluent is petroleum ether: ethyl acetate = 5:1), the eluent containing the target product is collected and the solvent is removed by rotary evaporator under reduced pressure to obtain 38.2 mg of a light yellow solid product phenanthridinone (yield 98%).
[0055] 1 H NMR (600 MHz, DMSO-d 6 )δ11.68(s,1H),8.50(d,J=8.2Hz,1H),8.38(d,J=8.0Hz,1H),8.33(d,J=7.9Hz,1H),7.85(t,J=9.5 Hz,1H),7.64(t,J=7.5Hz,1H),7.48(t,J=6.8Hz,1H),7.37(d,J=8.1Hz,1H),7.26(t,J=7.0Hz,1H). 13 C NMR (151 MHz, DMSO-d 6 )δ161.29,137.03,134.73,133.27,130.04,128.39,127.94,126.15,123.72,123.08,122.73,118.03,116.58.
[0056] Example 2
[0057] The structural formula of the phenanthridinone compound of this embodiment is as follows:
[0058]
[0059] The synthesis method of this embodiment is as follows: 2-iodo-N-(p-tolyl)benzamide (67.4mg, 0.2mmol), potassium polysulfide (1.12mg, 0.01mmol), potassium tert-butoxide (67.3mg, 0.6mmol) are sequentially loaded into a Shrek tube, toluene (2mL, 0.1M) is added to the glove box, the Shrek tube is removed from the glove box, and the mixture is stirred under a 427nm (40W) blue light lamp at room temperature for 1h. After the reaction is completed, ethyl acetate is added to the mixture for extraction and separation, the ethyl acetate organic phase is collected and dried with anhydrous sodium sulfate, and then filtered with a funnel, the filtrate is concentrated by a rotary evaporator under reduced pressure to remove the solvent, and the concentrate is purified by column chromatography (eluent is petroleum ether: ethyl acetate = 5:1), the eluent containing the target product is collected and the solvent is removed by rotary evaporation under reduced pressure to obtain a light yellow solid product 2-methylphenanthridone + 3-methylphenanthridone mixture of 39.7mg (yield 95%).
[0060] 1 H NMR (600 MHz, DMSO-d 6 )δ11.60(s,1H),8.48(d,J=8.2Hz,0.59H),8.43(d,J=8.1Hz,0.46H),8.30(t,J=9.8Hz,1H),8.25(d,J=7.5Hz,0.47H),8.19(s,0.60H), 7.82(m,1H),7.61(m,1H),7.27(dd,J=9.9Hz,26.7Hz,1H),7.15(s,0.46H),7.08(d,J=8.2Hz,0.46H),2.41(s,1.70H),2.38(s,1.32H). 13 C NMR (151 MHz, DMSO-d 6 )δ160.96,160.66,139.38,136.59,134.40,134.36,134.20,132.72,132.66,131.21,130.56,127.74,127.4 6,127.42,125.74,125.28,123.15,123.04,122.53,122.34,117.38,115.99,115.96,115.22,21.10,20.70.
[0061] Example 3
[0062] The structural formula of the phenanthridinone compound of this embodiment is as follows:
[0063]
[0064] The synthesis method of this embodiment is as follows: 2-iodo-N-(p-trifluoromethylphenyl)benzamide (78.2 mg, 0.2 mmol), potassium polysulfide (1.12 mg, 0.01 mmol), potassium tert-butoxide (67.3 mg, 0.6 mmol) are sequentially loaded into a Shrek tube, toluene (2 mL, 0.1 M) is added to the glove box, the Shrek tube is removed from the glove box, and the mixture is stirred under a 427 nm (40 W) blue light lamp at room temperature for 1 h. After the reaction is completed, ethyl acetate is added to the mixture for extraction and separation, the ethyl acetate organic phase is collected and dried with anhydrous sodium sulfate, and then filtered with a funnel, the filtrate is concentrated by a rotary evaporator under reduced pressure to remove the solvent, and the concentrate is purified by column chromatography (eluent is petroleum ether: ethyl acetate = 5:1), the eluent containing the target product is collected and the solvent is removed by rotary evaporation under reduced pressure to obtain a light yellow solid product 2-trifluoromethylphenanthridone 23.8 mg and 3-trifluoromethylphenanthridone 24.6 mg (total yield 92%).
[0065] 1 H NMR (600 MHz, DMSO-d 6 )δ11.92(s,1H),8.60(dd,J=18.0,8.4Hz,2H),8.35(d,J=7.9Hz,1H),7.91( t,J=7.6Hz,1H),7.74(t,J=7.5Hz,1H),7.68(s,1H),7.56(d,J=8.6Hz,1H). 13 C NMR (151 MHz, DMSO-d 6 )δ160.70,136.67,133.18,133.02,129.42,129.26,127.57,126.30,124.85,124.75,123.39,120.82,118.16,112.78.
[0066] 1 H NMR (600 MHz, DMSO-d 6 )δ12.01(s,1H),8.73(s,1H),8.68(d,J=8.2Hz,1H),8.34(d,J=7.9Hz,1H),7.89(t ,J=7.6Hz,1H),7.81(d,J=8.6Hz,1H),7.71(t,J=5.6Hz,1H),7.52(d,J=6.5Hz,1H). 13 C NMR (151 MHz, DMSO-d 6)δ160.93,139.29,133.31,133.15,128.86,127.48,125.94,125.85,123.24,122.88,122.67,120.91,117.70,116.95.
[0067] Example 4
[0068] The structural formula of the phenanthridinone compound of this embodiment is as follows:
[0069]
[0070] The synthesis method of this embodiment is as follows: 2-iodo-N-(p-tert-butylphenyl)benzamide (75.8 mg, 0.2 mmol), potassium polysulfide (1.12 mg, 0.01 mmol), potassium tert-butoxide (67.3 mg, 0.6 mmol) are sequentially loaded into a Shrek tube, toluene (2 mL, 0.1 M) is added to the glove box, the Shrek tube is removed from the glove box, and the mixture is stirred at room temperature under a 427 nm (40 W) blue light lamp for 1 h. After the reaction is completed, ethyl acetate is added to the mixture for extraction and separation, the ethyl acetate organic phase is collected and dried with anhydrous sodium sulfate, and then filtered with a funnel, the filtrate is concentrated by a rotary evaporator under reduced pressure to remove the solvent, and the concentrate is purified by column chromatography (eluent is petroleum ether: ethyl acetate = 5:1), the eluent containing the target product is collected and the solvent is removed by rotary evaporation under reduced pressure to obtain a light yellow solid product of 2-tert-butylphenanthridone 21.4 mg and 3-tert-butylphenanthridone 20.8 mg (total yield 84%).
[0071] 1 H NMR (600 MHz, DMSO-d 6 )δ11.55(s,1H),8.45(d,J=8.2Hz,1H),8.29(t,J=6.4Hz,2H),7.83(t,J=6.9H z,1H),7.61(t,J=7.7Hz,1H),7.40(s,1H),7.32(d,J=8.4Hz,1H),1.33(s,9H). 13 C NMR (151 MHz, DMSO-d 6 )δ160.92,152.49,136.40,134.24,132.72,127.46,125.42,122.97,122.40,119.94,115.17,112.46,34.58,30.91(3C).
[0072] 1 H NMR (600 MHz, DMSO-d 6)δ11.59(s,1H),8.58(d,J=8.2Hz,1H),8.31(d,J=9.4Hz,2H),8.29(s,1H),7.85(t,J=6.9 Hz,1H),7.63(t,J=7.4Hz,1H),7.55(d,J=8.5Hz,1H),7.31(d,J=7.1Hz,1H),1.38(s,9H). 13 C NMR (151 MHz, DMSO-d 6 )δ160.72,144.67,134.43,134.39,132.65,127.69,127.49,127.09,125.73,122.65,119.10,116.94,115.86,34.43,31.30(3C).
[0073] Example 5
[0074] The structural formula of the phenanthridinone compound of this embodiment is as follows:
[0075]
[0076] The synthesis method of this embodiment is as follows: 2-iodo-3-methyl-N-phenylbenzamide (67.4 mg, 0.2 mmol), potassium polysulfide (1.12 mg, 0.01 mmol), potassium tert-butoxide (67.3 mg, 0.6 mmol) are sequentially loaded into a Shrek tube, toluene (2 mL, 0.1 M) is added to the glove box, the Shrek tube is removed from the glove box, and the mixture is stirred under a 427 nm (40 W) blue light lamp at room temperature for 1 h. After the reaction is completed, ethyl acetate is added to the mixture for extraction and separation, the ethyl acetate organic phase is collected and dried with anhydrous sodium sulfate, and then filtered with a funnel, the filtrate is concentrated by a rotary evaporator under reduced pressure to remove the solvent, and the concentrate is purified by column chromatography (eluent is petroleum ether: ethyl acetate = 5:1), the eluent containing the target product is collected and the solvent is removed by rotary evaporation under reduced pressure to obtain 40.2 mg of a light yellow solid product 10-methylphenanthridinone (yield 96%).
[0077] 1 H NMR (600 MHz, DMSO-d 6 )δ11.70(s,1H),8.45(d,J=8.3Hz,1H),8.32(d,J=7.8Hz,1H),7.72(d,J=7.3Hz,1H),7.55(t,J =7.6Hz,1H),7.49(t,J=7.7Hz,1H),7.42(d,J=8.0Hz,1H),7.27(t,J=7.9Hz,1H),2.94(s,3H). 13C NMR (151 MHz, DMSO-d 6 )δ160.89,136.97,135.14,133.27,128.73,127.75,127.39,127.34,127.20,126.00,121.65,118.77,116.20,25.62.
[0078] Experiments were conducted to synthesize phenanthridinone compounds using different photocatalysts, solvents and bases. The specific results are shown in Tables 1-3 below.
[0079] Table 1 Photocatalyst screening for the synthesis of phenanthridinone compounds catalyzed by visible light
[0080]
[0081] Table 2 Solvent screening for the synthesis of phenanthridinone compounds catalyzed by visible light
[0082]
[0083] Table 3 Screening of bases for the synthesis of phenanthridinone compounds catalyzed by visible light
[0084]
[0085] From the results in Tables 1-3, it can be seen that the product yield synthesized using potassium polysulfide as the photocatalyst, toluene as the solvent, and potassium tert-butoxide as the base is the highest and is the best choice.
[0086] Those skilled in the art should understand that the discussion of any of the above embodiments is only exemplary and is not intended to imply that the scope of the present invention is limited to these examples; under the concept of the present invention, the technical features in the above embodiments or different embodiments can also be combined, the steps can be implemented in any order, and there are many other changes in different aspects of the present invention as described above, which are not provided in detail for the sake of simplicity. Any omissions, modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. A method for synthesizing phenanthridinone compounds based on visible light catalysis, characterized in that: The method uses an N-aryl o-iodobenzamide derivative as a raw material, and under the excitation of a photocatalyst and the catalysis of a base, hydrogen iodide is removed to form a phenyl radical, which then undergoes a cyclization reaction to generate a phenanthridinone compound. The structural formula of the N-aryl o-iodobenzamide derivative is shown in Formula I below: The structural formula of the phenanthridinone compound is shown in Formula II below: Among them, R 1 is one of hydrogen, fluorine, chlorine, bromine, methyl or methoxy; the R 2 It is one of hydrogen, fluorine, chlorine, bromine, methyl, methoxy, cyano, trifluoromethyl or tert-butyl.
2. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 1, characterized in that: The specific steps include: 1) Adding the raw material of formula I, the photocatalyst and the base into a Shrek tube in sequence; 2) Place the Shrek tube into a glove box and add a reaction solvent into the glove box; 3) Move the Shrek tube out of the glove box and place it under blue light for reaction at room temperature; 4) After the reaction is completed, the reaction mixture in the Shrek tube is transferred to a separatory funnel and ethyl acetate is added for extraction; 5) collecting the ethyl acetate organic phase, drying it with anhydrous sodium sulfate, filtering it with a funnel, and concentrating the filtrate with a rotary evaporator to dryness; 6) The obtained concentrate is separated and purified by column chromatography to obtain the final phenanthridinone compound.
3. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 1 or 2, characterized in that: The photocatalyst is one or a combination of 10-mesityl-10-H-phenothiazine, ammonium tetrathiotungstate, tris(2,2″-bipyridyl)ruthenium(I) chloride hexahydrate or potassium polysulfide.
4. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 1 or 2, characterized in that: The base is one or a combination of potassium tert-butoxide, sodium tert-butoxide, potassium carbonate, cesium carbonate, and triethylamine.
5. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 1 or 2, characterized in that: The molar ratio of the raw material of formula I to the photocatalyst and the base is: 1:0.1-0.01:1-5.
6. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 2, characterized in that: The reaction solvent is selected from one or more of acetonitrile, tetrahydrofuran, acetone, toluene, and 1,4-dioxane; the amount of the reaction solvent is based on the substrate raw material of formula I, so that the concentration range of the raw material of formula I in the solvent is 0.05-0.10M.
7. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 2, characterized in that: The eluent used for separation and purification is a mixture of petroleum ether and ethyl acetate, and the ratio of petroleum ether to ethyl acetate is 10:1-5:
1.
8. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 2, characterized in that: The time of the room temperature irradiation reaction is 1-12 hours.
9. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 2, characterized in that: The wavelength range of the blue light is 420-427 nm.
10. The method for synthesizing phenanthridinone compounds based on visible light catalysis according to claim 2, characterized in that: The blue light source adopts a blue light lamp, and the power of the blue light lamp is 5-40W.
Citation Information
Cited By
Preparation method of phenanthridine compound
CN122404224A
